{"title":"基于沃罗涅日地区登记数据的伊洛前列素对fc - iv型肺动脉高压患者的有效性","authors":"O. M. Korolkova, T. Chernykh","doi":"10.38109/2225-1685-2019-2-76-83","DOIUrl":null,"url":null,"abstract":"The purpose of the study: to study the effectiveness of the use of the drug iloprost in patients with PH III - IV FC according to the register of the Voronezh region. The material was the base register data. The effectiveness of the drug «iloprost» evaluated in patients with PH III - IV FC according to the register. The safety of therapy «iloprost» shown on the basis of a complex of clinical and hemodynamic parameters.Glinical example presented.","PeriodicalId":11859,"journal":{"name":"Eurasian heart journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA\",\"authors\":\"O. M. Korolkova, T. Chernykh\",\"doi\":\"10.38109/2225-1685-2019-2-76-83\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The purpose of the study: to study the effectiveness of the use of the drug iloprost in patients with PH III - IV FC according to the register of the Voronezh region. The material was the base register data. The effectiveness of the drug «iloprost» evaluated in patients with PH III - IV FC according to the register. The safety of therapy «iloprost» shown on the basis of a complex of clinical and hemodynamic parameters.Glinical example presented.\",\"PeriodicalId\":11859,\"journal\":{\"name\":\"Eurasian heart journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eurasian heart journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.38109/2225-1685-2019-2-76-83\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian heart journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38109/2225-1685-2019-2-76-83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
该研究的目的:根据沃罗涅日地区的登记，研究药物伊洛前列素在PH III - IV FC患者中使用的有效性。材料是基本寄存器数据。根据注册表，评估了药物“伊洛前列素”在PH III - IV型FC患者中的有效性。治疗«伊洛前列素»的安全性显示在复杂的临床和血流动力学参数的基础上。提出临床实例。
EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
The purpose of the study: to study the effectiveness of the use of the drug iloprost in patients with PH III - IV FC according to the register of the Voronezh region. The material was the base register data. The effectiveness of the drug «iloprost» evaluated in patients with PH III - IV FC according to the register. The safety of therapy «iloprost» shown on the basis of a complex of clinical and hemodynamic parameters.Glinical example presented.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
